News Releases

Feb 26, 2024
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
LOUISVILLE, Colo. --(BUSINESS WIRE)--Feb. 26, 2024-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton , Chief Executive Officer of Biodesix , will present and host in-person 1x1 investor meetings at the TD Cowen
Displaying 11 - 12 of 12